Health and Happiness (H&H) International Holdings Limited (HK:1112)
:1112
1112 Stock Chart & Stats
HK$14.19
-HK$0.04(-0.48%)
At close: 4:00 PM EST
HK$14.19
-HK$0.04(-0.48%)
Day’s Range― - ―
52-Week RangeHK$8.11 - HK$16.80
Previous CloseN/A
Volume756.14K
Average Volume (3M)2.14M
Market Cap
HK$8.11B
Enterprise ValueHK$14.44B
Total Cash (Recent Filing)HK$1.73B
Total Debt (Recent Filing)HK$9.06B
Price to Earnings (P/E)39.6
Beta0.72
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.77%
Share Statistics
EPS (TTM)0.21
Shares Outstanding645,561,340
10 Day Avg. Volume985,367
30 Day Avg. Volume2,140,320
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.26
Price to Sales (P/S)0.54
P/FCF Ratio7.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$17.45Price Target Upside22.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)1.12
Revenue Forecast (FY)HK$15.75B
Bulls Say, Bears Say
Bulls Say
High Gross MarginsGross margins around 60–64% provide durable core economics and pricing flexibility. High product-level margins enable reinvestment in marketing, distribution and R&D without immediate margin erosion, supporting sustained profitability even through cyclical or competitive pressures.
Consistent Free Cash FlowConsistently positive free cash flow, roughly HK$0.95B in 2025 and ~95% of net income, shows strong cash conversion and operational cash generation. This cash supports working capital, capex and gradual debt paydown, enhancing long-term financial resilience despite earnings swings.
Resilient Revenue TrendsA modest revenue rebound in 2025 (+4.5%) after a slight 2024 decline indicates resilient consumer demand for branded health products. Combined with multi-channel offline and online distribution, steady top-line trends support predictable cash flow and long-term market share maintenance.
Bears Say
Elevated LeverageLeverage around 1.5–1.6 materially reduces financial flexibility and raises refinancing and interest-rate risk. Elevated debt magnifies the impact of earnings volatility, constraining the firm's ability to fund growth or absorb shocks without improving cash generation or executing credible deleveraging.
Earnings Volatility & Weak ROEEarnings swung to a loss in 2024 and recovered only thinly in 2025 (net margin ~1.4%), while ROE dropped from ~18% in 2020 to ~3% in 2025. Persistent profit volatility and weakened returns impair reinvestment capacity and increase execution risk for strategic initiatives.
Limited Deleveraging CapacityFree cash flow declined ~20.6% in 2025 and operating cash flow covers only a small portion of debt (~0.22), implying slow deleveraging under current trends. Without a sustainable cash rebound, reducing leverage or funding growth without more debt will be gradual and may pressure strategic flexibility.
Health and Happiness (H&H) International Holdings News
1112 FAQ
What was Health and Happiness (H&H) International Holdings Limited’s price range in the past 12 months?
Health and Happiness (H&H) International Holdings Limited lowest stock price was HK$8.11 and its highest was HK$16.80 in the past 12 months.
What is Health and Happiness (H&H) International Holdings Limited’s market cap?
Health and Happiness (H&H) International Holdings Limited’s market cap is HK$8.11B.
When is Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date?
Health and Happiness (H&H) International Holdings Limited’s upcoming earnings report date is Sep 01, 2026 which is in 145 days.
How were Health and Happiness (H&H) International Holdings Limited’s earnings last quarter?
Health and Happiness (H&H) International Holdings Limited released its earnings results on Mar 24, 2026. The company reported HK$0.213 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.213.
Is Health and Happiness (H&H) International Holdings Limited overvalued?
According to Wall Street analysts Health and Happiness (H&H) International Holdings Limited’s price is currently Undervalued.
Does Health and Happiness (H&H) International Holdings Limited pay dividends?
Health and Happiness (H&H) International Holdings Limited pays a Quarterly dividend of HK$0.19 which represents an annual dividend yield of 1.77%. See more information on Health and Happiness (H&H) International Holdings Limited dividends here
What is Health and Happiness (H&H) International Holdings Limited’s EPS estimate?
Health and Happiness (H&H) International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Health and Happiness (H&H) International Holdings Limited have?
Health and Happiness (H&H) International Holdings Limited has 645,561,340 shares outstanding.
What happened to Health and Happiness (H&H) International Holdings Limited’s price movement after its last earnings report?
Health and Happiness (H&H) International Holdings Limited reported an EPS of HK$0.213 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.777%.
Which hedge fund is a major shareholder of Health and Happiness (H&H) International Holdings Limited?
Currently, no hedge funds are holding shares in HK:1112
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Health and Happiness (H&H) International Holdings Limited
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
Health and Happiness (H&H) International Holdings (1112) Earnings & Revenues
1112 Company Deck
1112 Earnings Call
Q4 2026
0:00 / 0:00
1112 Stock 12 Month Forecast
Average Price Target
HK$17.45
▲(22.96% Upside)
Technical Analysis
Want Want China Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―
China Feihe Limited
―
Options Prices
Currently, No data available
---